These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 26078409)

  • 1. High-Throughput Screening for Positive Allosteric Modulators Identified Potential Therapeutics against Acetylcholinesterase Inhibition.
    Chapleau RR; McElroy CA; Ruark CD; Fleming EJ; Ghering AB; Schlager JJ; Poeppelman LD; Gearhart JM
    J Biomol Screen; 2015 Oct; 20(9):1142-9. PubMed ID: 26078409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of new allosteric sites and modulators of AChE through computational and experimental tools.
    Roca C; Requena C; Sebastián-Pérez V; Malhotra S; Radoux C; Pérez C; Martinez A; Antonio Páez J; Blundell TL; Campillo NE
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1034-1047. PubMed ID: 29873262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning.
    Saifina LF; Abdalla M; Gubaidullina LM; Zueva IV; Eltayb WA; El-Arabey AA; Kharlamova AD; Lenina OA; Semenov VE; Petrov KA
    Eur J Med Chem; 2023 Jan; 246():114949. PubMed ID: 36462442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible cholinesterase inhibitors as pretreatment for exposure to organophosphates. A review.
    Lorke DE; Petroianu GA
    J Appl Toxicol; 2019 Jan; 39(1):101-116. PubMed ID: 30027640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the value of huperzine as pretreatment of organophosphate poisoning.
    Lallement G; Baille V; Baubichon D; Carpentier P; Collombet JM; Filliat P; Foquin A; Four E; Masqueliez C; Testylier G; Tonduli L; Dorandeu F
    Neurotoxicology; 2002 May; 23(1):1-5. PubMed ID: 12164543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning.
    Lenina OA; Zueva IV; Zobov VV; Semenov VE; Masson P; Petrov KA
    Sci Rep; 2020 Oct; 10(1):16611. PubMed ID: 33024231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of OpdA, an organophosphorus (OP) hydrolase, prevents lethality in an African green monkey model of acute OP poisoning.
    Jackson CJ; Carville A; Ward J; Mansfield K; Ollis DL; Khurana T; Bird SB
    Toxicology; 2014 Mar; 317():1-5. PubMed ID: 24447378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel and selective acetylcholinesterase inhibitors for Tetranychus cinnabarinus (Acari: Tetranychidae).
    Bu C; Peng B; Cao Y; Wang X; Chen Q; Li J; Shi G
    Insect Biochem Mol Biol; 2015 Nov; 66():129-35. PubMed ID: 26520174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ex vivo approach for the evaluation of reversible inhibitors as potential pretreatments against organophosphate toxicity.
    Tonduli LS; Doctor BP; Saxena A
    Chem Biol Interact; 2005 Dec; 157-158():426-7. PubMed ID: 16429574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of acetylcholinesterase inhibitors using homogenous cell-based assays in quantitative high-throughput screening platforms.
    Li S; Huang R; Solomon S; Liu Y; Zhao B; Santillo MF; Xia M
    Biotechnol J; 2017 May; 12(5):. PubMed ID: 28294544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ortho-7 bound to the active-site gorge of free and OP-conjugated acetylcholinesterase: cation-π interactions.
    Pathak AK; Bandyopadhyay T
    Biopolymers; 2016 Jan; 105(1):10-20. PubMed ID: 26270602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholinesterase prophylaxis against organophosphate poisoning. Quantitative correlation between protection and blood-enzyme level in mice.
    Raveh L; Ashani Y; Levy D; De La Hoz D; Wolfe AD; Doctor BP
    Biochem Pharmacol; 1989 Feb; 38(3):529-34. PubMed ID: 2917010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment.
    Bajgar J
    Adv Clin Chem; 2004; 38():151-216. PubMed ID: 15521192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers.
    Pang Z; Hu CM; Fang RH; Luk BT; Gao W; Wang F; Chuluun E; Angsantikul P; Thamphiwatana S; Lu W; Jiang X; Zhang L
    ACS Nano; 2015 Jun; 9(6):6450-8. PubMed ID: 26053868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review on experimental and clinical findings in intermediate syndrome caused by organophosphate poisoning.
    Abdollahi M; Karami-Mohajeri S
    Toxicol Appl Pharmacol; 2012 Feb; 258(3):309-14. PubMed ID: 22177963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DMSO: A Mixed-Competitive Inhibitor of Human Acetylcholinesterase.
    Kumar A; Darreh-Shori T
    ACS Chem Neurosci; 2017 Dec; 8(12):2618-2625. PubMed ID: 29017007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of polyhydroxyfullerenes on organophosphate-induced toxicity in mice.
    Ehrich M; Hinckley J; Werre SR; Zhou Z
    Toxicology; 2020 Dec; 445():152586. PubMed ID: 32949634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential new therapeutic modality revealed through agent-based modeling of the neuromuscular junction and acetylcholinesterase inhibition.
    Chapleau RR; Robinson PJ; Schlager JJ; Gearhart JM
    Theor Biol Med Model; 2014 Oct; 11():42. PubMed ID: 25273339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploratory study; the gap between real reference interval and currently used reference interval of RBC AChE activities in South Korea.
    Seong Y; Moon J; Chun B; Cho Y
    J Toxicol Environ Health A; 2022 Sep; 85(18):739-749. PubMed ID: 35635073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acetylcholinesterase (AChE) point-of-care testing in OP poisoning on knowledge, attitudes and practices of treating physicians in Sri Lanka.
    Rajapakse BN; Neeman T; Buckley NA
    BMC Health Serv Res; 2014 Mar; 14():104. PubMed ID: 24589276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.